We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Oliver Wyman's AI validation framework demonstrates how a rigorous validation framework can be executed efficiently in practice.
How to use a cost utility analysis to evaluate your digital health product.
First published during the 2022 to 2024 Sunak Conservative government
The Intellectual Property Office offers different methods of accelerating the processing of your patent application.
Sections (89B.01 - 89B.18) updated January 2023.
First published during the 2019 to 2022 Johnson Conservative government
Following a review, the MHRA has updated previous guidance (DSI/2022/003) on the use of paclitaxel coated devices (PCD) in the treatment of peripheral arterial disease (PAD).
Study of the experience of electronic monitoring, and how this can be used most effectively to achieve best outcomes, including compliance, rehabilitation and desistance.
Allowing multiple applications.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).